Comparison of effectiveness of iontophoresis with methotrexate gel 1% and topical tazarotene 0.1%in the treatment of nail psoriasis
Phase 4
- Conditions
- Health Condition 1: L408- Other psoriasis
- Registration Number
- CTRI/2023/03/051005
- Lead Sponsor
- MGM Medical College and Hospial Aurangabad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All OPD and IPD patients with nail psoriasis above the age of 18yrs.
Exclusion Criteria
1.patients on systemic therapy for psoriasis
2.patients having pacemaker, metal orthopedic implants ,cardiac arrhythmias, hypersensitivity to methotrexate and tazarotene
3.pregnancy and lactating females.
4.patients with hematological or hepatic disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The comparative study of efficacy of iontophoresis with methotrexate gel 1% and topical tazarotene 0.1% in the treatment of nail psoriasis. <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 1.nail changes prior to start of the trail <br/ ><br>2.nail changes every 1 month measured with help of modified NAPSI score. <br/ ><br> <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.improvement in nail changes <br/ ><br>2.changes in modified NAPSI score <br/ ><br>Timepoint: 1.mNAPSI score every monthly for 3 months <br/ ><br>2.DLQI score at the start of trail